JP2003119141A5 - - Google Patents

Download PDF

Info

Publication number
JP2003119141A5
JP2003119141A5 JP2001313977A JP2001313977A JP2003119141A5 JP 2003119141 A5 JP2003119141 A5 JP 2003119141A5 JP 2001313977 A JP2001313977 A JP 2001313977A JP 2001313977 A JP2001313977 A JP 2001313977A JP 2003119141 A5 JP2003119141 A5 JP 2003119141A5
Authority
JP
Japan
Prior art keywords
hepronicart
vitamin
weight ratio
oral administration
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001313977A
Other languages
Japanese (ja)
Other versions
JP2003119141A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2001313977A priority Critical patent/JP2003119141A/en
Priority claimed from JP2001313977A external-priority patent/JP2003119141A/en
Priority to TW091120354A priority patent/TWI244921B/en
Priority to CNB021439834A priority patent/CN1219514C/en
Priority to KR1020020060903A priority patent/KR20030030882A/en
Publication of JP2003119141A publication Critical patent/JP2003119141A/en
Priority to HK03107057A priority patent/HK1054695A1/en
Publication of JP2003119141A5 publication Critical patent/JP2003119141A5/ja
Pending legal-status Critical Current

Links

Claims (1)

ヘプロニカートとビタミンＥの重量比が、１：１００〜１００：１である請求項第１項または第２項記載の経口投与製剤。The oral administration preparation according to claim 1 or 2, wherein the weight ratio of hepronicart to vitamin E is 1: 100 to 100: 1.
JP2001313977A 2001-10-11 2001-10-11 Oral administration preparation having improved absorbability Pending JP2003119141A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (en) 2001-10-11 2001-10-11 Oral administration preparation having improved absorbability
TW091120354A TWI244921B (en) 2001-10-11 2002-09-05 Oral administration medicine with improving absorbability
CNB021439834A CN1219514C (en) 2001-10-11 2002-09-29 Oral medicine preparation with high absorbency
KR1020020060903A KR20030030882A (en) 2001-10-11 2002-10-07 Oral administration preparation improved in absorbability
HK03107057A HK1054695A1 (en) 2001-10-11 2003-09-30 Oral administration preparation improved in absorbability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (en) 2001-10-11 2001-10-11 Oral administration preparation having improved absorbability

Publications (2)

Publication Number Publication Date
JP2003119141A JP2003119141A (en) 2003-04-23
JP2003119141A5 true JP2003119141A5 (en) 2005-06-09

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001313977A Pending JP2003119141A (en) 2001-10-11 2001-10-11 Oral administration preparation having improved absorbability

Country Status (5)

Country Link
JP (1) JP2003119141A (en)
KR (1) KR20030030882A (en)
CN (1) CN1219514C (en)
HK (1) HK1054695A1 (en)
TW (1) TWI244921B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4721631B2 (en) * 2003-09-30 2011-07-13 小林製薬株式会社 Hypnotic composition
JP4780907B2 (en) * 2003-09-30 2011-09-28 小林製薬株式会社 Hypnotic composition
JP5094899B2 (en) * 2010-03-23 2012-12-12 小林製薬株式会社 Hypnotic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (en) * 1984-12-24 1986-07-09 Kanebo Ltd Preparation of vitamin k2 medicine for oral administration
JPS63310827A (en) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd Sustained release pharmaceutical containing nicotinic aid derivative as principal agent
JPH10130171A (en) * 1996-09-04 1998-05-19 Dot:Kk Pharmaceutical composition for oral administration
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Similar Documents

Publication Publication Date Title
JP2003520232A5 (en)
NO2017047I1 (en) Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, including citrate salt
JP2003503454A5 (en)
JP2004523498A5 (en)
JP2004529078A5 (en)
JP2004515500A5 (en)
JP2004525194A5 (en)
EA200301165A1 (en) Drug on the basis of oxycodone
NO330947B1 (en) The use of oxcarbazepine-containing pharmaceutical compositions in the fasted state
JP2006503588A5 (en)
JP2002532112A5 (en)
JP2006507281A5 (en)
JP2002506648A5 (en)
JP2003514758A5 (en)
HK1070053A1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
ITMI20011337A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT
JP2001522820A5 (en)
JP2004002446A5 (en)
DE60205888D1 (en) THE CITRATE SALT OF 5,8,14-TRIAZATE-REACYCLO (10.3.1.02, 11.04.9) -HEXADECA-2 (11), 3,5,7,9-PENTAENE
ITMI20011338A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
JP2006505391A5 (en)
JP2001513504A5 (en)
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
JP2004517961A5 (en)
JP2003119141A5 (en)